Verzenio Is Significant– Cuts The Risk of Cancer Coming Back In Some Women With Early Breast Cancer– A First For CDK4/6 Inhibitors

Updated June 29th, 2020

Verzenio Is Significant– Cuts The Risk of Cancer Coming Back In Some Women With Early Breast Cancer– A First For CDK4/6 Inhibitors

During a clinical trial, researchers found that CDK4/CDK6 inhibitor Verzenio may have a huge impact on women battling early stage breast cancer by decreasing the likelihood of the cancer returning.

NOW
PLAYING
After Breast Cancer Diagnosis a Woman, 33, Was Told Her Ovaries were ‘Dead’ But Miraculously Gives Birth to 2nd Child
NOW
PLAYING
Days After Giving Birth to Twins, New Mom, 26, Told She Has Incurable Breast Cancer
NOW
PLAYING
Breast Cancer & Bone Health: What You Need to Know
NOW
PLAYING
Maya Rudolph, 48, Continues to Dominate 'SNL' and the Comedic World After Facing Grief as a Child; Her Mom, Soul Singer Minnie Riperton, Passed from Breast Cancer in 1979
NOW
PLAYING
Many Women Say They're Drinking More During Pandemic, 70% Don't Know Alcohol Increases Cancer Risk, According to SurvivorNet Survey
NOW
PLAYING
Do Chemicals Cause Breast Cancer? It’s Unknown, but Two Researchers Say That the Government Should Do More to Protect Women

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV

Treatment: Lymphedema

SEE MORE   

Treatment: Lymphedema

Lymphedema is a chronic swelling that can occur after breast cancer surgery and radiation.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.